Investing SVN-015 Advances into Further NIDA-Funded Studies Following Encouraging Finance News Aug 9, 2026 Solvonis Therapeutics plc (LSE: SVNS), a late clinical-stage biopharmaceutical company developing novel… Read More...
Investing Environmental Approval for Boland Infield Studies & Update on Scaled Column Finance News Sep 18, 2025 In May 2024, the Biden administration imposed a 25 percent tariff on Chinese rare earth magnets starting in 2026,… Read More...